Product
Hetrombopag Olamine
Aliases
Hetrombopag, Hetrombopag Olamine+Standard Therapy
Name
Hetrombopag
4 clinical trials
1 drug
5 indications
Indication
Aplastic AnemiaIndication
Severe Aplastic AnemiaIndication
Chemotherapy-Induced ThrombocytopeniaIndication
ThrombocytopeniaIndication
Radiotherapy Side EffectClinical trial
A Phase III Multicenter Randomized Study of Hetrombopag or Placebo in Treatment-Naive Severe Aplastic AnemiaStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Bioequivalence Study of Different Formulations of Hetrombopag Olamine Tablets in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-07-25
Clinical trial
A Randomized, Controlled Study on the Efficacy and Safety of Hetrombopag in the Treatment of Chemotherapy-induced Thrombocytopenia(CIT) in Patients With Acute Myeloid LeukemiaStatus: Not yet recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Single-arm, Phase II Trial of Hetrombopag for the Treatment of Concurrent Chemoradiotherapy-induced Thrombocytopenia in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-05-30